Sangamo Therapeutics
SGMO
$1.70
Share price
-2.30%
Change (1 day)
-70.33%
Change (1 year)
Categories
EPS for Sangamo Therapeutics (SGMO)
EPS in 2022 (TTM): -$1.25
According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.25. In 2021 the company made an earnings per share (EPS) of -$1.24 a decrease over its 2020 EPS that were of -$0.93.
EPS history for Sangamo Therapeutics from 2011 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$1.25 | 0.81% |
| 2021 | -$1.24 | 33.33% |
| 2020 | -$0.93 | 6.9% |
| 2019 | -$0.87 | 22.54% |
| 2018 | -$0.71 | 1.43% |
| 2017 | -$0.70 | -31.37% |
| 2016 | -$1.02 | 75.86% |
| 2015 | -$0.58 | 48.72% |
| 2014 | -$0.39 | -17.02% |
| 2013 | -$0.47 | 9.3% |
| 2012 | -$0.43 | -39.44% |
| 2011 | -$0.71 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $6.83 | -646.36% | 🇺🇸 USA |
 Amgen AMGN | $12.18 | -1,074.40% | 🇺🇸 USA |
 Biogen BIIB | $20.99 | -1,779.20% | 🇺🇸 USA |
 Dow DOW | $6.29 | -603.20% | 🇺🇸 USA |
 Gilead Sciences GILD | $3.67 | -393.60% | 🇺🇸 USA |
 Merck MRK | $5.73 | -558.40% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$9.29 | 643.20% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.77 | -161.49% | 🇺🇸 USA |